发明授权
- 专利标题： SUBSTITUTED HETEROCYCLIC AMIDES
- 专利标题（中）： 取代的杂环酰胺
-
申请号： EP01958825.0申请日： 2001-07-18
-
公开(公告)号： EP1307444B1公开(公告)日： 2007-10-03
- 发明人: HERRON, David, Kent , JOSEPH, Sajan , MARQUART, Angela, Lynn , MASTERS, John, Joseph , MENDEL, David , SMITH, Gerald, Floyd , WAID, Philip, Parker , WILEY, Michael, Robert , YEE, Ying, Kwong
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center, Drop Code 1104 Indianapolis, IN 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center, Drop Code 1104 Indianapolis, IN 46285 US
- 代理机构： Suarez-Miles, Ana Sanchiz
- 优先权： US221092P 20000727
- 国际公布： WO2002010154 20020207
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; C07D401/12 ; C07D213/81 ; C07D237/24 ; A61K31/4402 ; A61K31/444 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61P7/02
摘要：
This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
公开/授权文献
- EP1307444A2 SUBSTITUTED HETEROCYCLIC AMIDES 公开/授权日：2003-05-07
信息查询
